Skip to main content

Relationship Between the Exposure of Glucocorticoids During Pregnancy and Orofacial Cleft Development

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Bayer
BayerLEVERKUSEN, Germany
1 program
Diflucortolone valerateN/A
Leo Pharma
Leo PharmaDenmark - Ballerup
1 program
Diflucortolone valerateN/A1 trial
Active Trials
NCT03788863Completed99,999Est. Nov 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Leo PharmaDiflucortolone valerate

Clinical Trials (1)

Total enrollment: 99,999 patients across 1 trials

NCT03788863Leo PharmaDiflucortolone valerate

A Study to Learn More About the Relationship Between the Development of a Gap in the Upper Lip (Cleft Lip) or in the Roof of the Mouth (Cleft Palate) in Newborns and the Use of Glucocorticoids by the Mother During Pregnancy: a Meta-analysis

Start: Nov 2018Est. completion: Nov 201899,999 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.